Authors
Latest:
Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and AdvocacyInfectious diseases clinicians turn to Twitter as a tool for education and collaboration.
Latest:
Eosinophils, Fevers, and Diarrhea With a Surprise Diagnosis in a Patient With AIDSWhen the CD4 count seems too good to be true.
Latest:
Update on Candida auris: Statistics, Detection, and a Phase 2 TrialAs of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.
Latest:
Long-Acting Anti-MRSA Agents: One Dose to Cure?A review of the current literature and future directions.
Latest:
Resources Available for Patients with HIV Drug ResistanceThe panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.
Latest:
Texas State Scientist on Rabies Eradication, Campus Reopening, and AMRDr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.
Latest:
Candida Auris: The Rise of a New Fungal ThreatCandida auris—Are we prepared for another multidrug-resistant pathogen?
Latest:
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportA death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Latest:
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract InfectionsSeveral recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Latest:
Globalization of Antibiotic Stewardship Programs: The World Is WaitingThe globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
Latest:
Suffering through COVID-19: A Doctor's Personal JourneyFrontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.
Latest:
Hospital-Acquired and Ventilator-Associated Pneumonia: Highlights and Pitfalls of the 2016 IDSA / ATS GuidelinesHospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.
Latest:
ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT PatientsThis In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.
Latest:
Exploring Primary Prophylaxis for Invasive Pulmonary AspergillosisInvasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.
Latest:
Searching for the Cause of Hearing Loss in a Patient With HIVEarly diagnosis and treatment were essential to ensuring a good prognosis.
Latest:
Doravirine: Researchers DRIVE for a Drug Ahead of Its ClassA novel NNRTI hits the market, but what place will it have in treatment?
Latest:
Aging HIV-Infected Population Faces Unique ChallengesAs the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.
Latest:
Reviewing Real-World Cases of C diff BiotherapeuticHere is a brief report of 5 cases of the use of fecal microbiota, live-jslm (Rebyota) in the management of recurrent Clostridioides difficile infection.
Latest:
Considerations for Aerosolized Antibiotics in Multidrug-Resistant Gram-Negative PneumoniaAerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.
Latest:
Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary InvolvementA shocking find on a CT scan leads to an unexpected diagnosis.
Latest:
Never Ignore a New Rash in a Patient With AIDSA case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.
Latest:
ABSSSI and OPAT: Key MessagesPanelists hypothesize on theoretical downsides of resistance development for gram-negative infections and reflect on the importance of implementing outpatient parenteral antibiotic therapy.
Latest:
Undetectable Equals UntransmittableA breakthrough message for patients that must be delivered correctly by health care providers. The Undetectable Equals Untransmittable, or U=U, move­ment is a global campaign definitively stating that people living with HIV (PLWH) who have undetectable HIV RNA are unable to transmit HIV. By educating people, the hope is that they will get tested and, if necessary, start and stay on treatment. This message has been endorsed by many organizations, including the US Centers for Disease Control and Prevention and the HIV Medicine Association.
Latest:
Antibiotic Resistance: Challenges and Opportunities for Treating Serious Bacterial Skin InfectionsAs current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.
